Search

Tag: #intelligent-agents8 results

Aureka Raises $35M for AI Antibody Platform

Aureka Raises $35M for AI Antibody Platform

Aureka Biotechnologies completed a $35M Series A+ funding round led by Sequoia China to advance its AuraIDE™ AI platform for antibody design. Funds will boost base models, intelligent agents, and high-throughput experimental infrastructure. The company's first AI-designed antibody drug nears clinical trials.